Celator Pharmaceuticals (CPXX) Tops Q3 EPS by 1c

Celator Pharmaceuticals (NASDAQ: CPXX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Celator Pharmaceuticals (CPXX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Grocery Outlet Holding (GO) PT Raised to $12 at TD Cowen